The value and scope of subspecialty biomedical journals: Perspectives from either side of the Atlantic

Por Robert Vassallo, Marco Confalonieri, Barbara Yawn
Publicado no Cardiocore (2015)

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new Europ...

Por Andrea Gramegna, Stefano Aliberti, Marco Confalonieri, Angelo Corsico, Luca Richeldi, Carlo Vancheri, Francesco Blasi
Publicado em 2018-10-01

Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease

Por Mitja, Jevnikar, Metka, Kodric, Fabiana, Cantarutti, Cifaldi, Rossella, Longo, Cinzia, Rossana, Della Porta, Bruno, Bembi, Marco, Confalonieri
Publicado no Mol Genet Metab Rep (2015)

Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease

Por Matthias Boentert, Hélène Prigent, Katalin Várdi, Harrison N. Jones, Uwe Mellies, Anita K. Simonds, Stephan Wenninger, Emilia Barrot Cortés, Marco Confalonieri
Publicado em 2016-10-01

Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study

Por Andrea Vianello, Francesco Salton, Beatrice Molena, Cristian Turato, Maria Laura Graziani, Fausto Braccioni, Valeria Frassani, Dino Sella, Paolo Pretto, Luciana Paladini, Andi Sukthi, Marco Confalonieri
Publicado em 2020-02-01